Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Psychiatric Rehabilitation × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Esophageal Neoplasms 2 Depression 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Vomiting 1 Uterine Cervical Neoplasms 1 Tobacco Use Disorder 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nausea 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 temsirolimus 2 poly ICLC 2 palbociclib 2 etoposide phosphate 2 antineoplaston AS 2-1 2 antineoplaston A10 2 Vincristine 2 Sunitinib 2 Sirolimus 2 Everolimus 2 Dasatinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 tandutinib 1 selinexor 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡